Business
AI summaryValneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. Its marketed products include IXIARO for Japanese encephalitis, DUKORAL for cholera and travelers' diarrhea, and IXCHIQ against chikungunya. The company's pipeline includes candidates targeting Lyme disease, shigellosis, Zika, human metapneumovirus, Clostridium difficile, and Epstein-Barr virus. It sells its products in North America, Europe, and internationally, and is based in Saint-Herblain, France.
